Boston Scientific Corp (BSX)
73.68
-0.42
(-0.57%)
USD |
NYSE |
May 10, 16:00
73.68
0.00 (0.00%)
After-Hours: 20:00
Boston Scientific Enterprise Value: 117.47B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 09, 2024 | 117.47B |
May 08, 2024 | 115.44B |
May 07, 2024 | 116.48B |
May 06, 2024 | 115.19B |
May 03, 2024 | 115.63B |
May 02, 2024 | 114.43B |
May 01, 2024 | 114.69B |
April 30, 2024 | 114.19B |
April 29, 2024 | 115.12B |
April 26, 2024 | 116.09B |
April 25, 2024 | 116.22B |
April 24, 2024 | 115.71B |
April 23, 2024 | 109.94B |
April 22, 2024 | 108.52B |
April 19, 2024 | 107.50B |
April 18, 2024 | 107.64B |
April 17, 2024 | 108.43B |
April 16, 2024 | 108.66B |
April 15, 2024 | 107.67B |
April 12, 2024 | 108.59B |
April 11, 2024 | 109.72B |
April 10, 2024 | 109.44B |
April 09, 2024 | 109.46B |
April 08, 2024 | 109.50B |
April 05, 2024 | 109.31B |
Date | Value |
---|---|
April 04, 2024 | 108.12B |
April 03, 2024 | 108.68B |
April 02, 2024 | 107.68B |
April 01, 2024 | 108.64B |
March 31, 2024 | 109.21B |
March 28, 2024 | 109.15B |
March 27, 2024 | 109.34B |
March 26, 2024 | 108.34B |
March 25, 2024 | 107.39B |
March 22, 2024 | 107.87B |
March 21, 2024 | 107.79B |
March 20, 2024 | 107.61B |
March 19, 2024 | 108.12B |
March 18, 2024 | 107.32B |
March 15, 2024 | 105.83B |
March 14, 2024 | 106.76B |
March 13, 2024 | 105.55B |
March 12, 2024 | 107.68B |
March 11, 2024 | 105.67B |
March 08, 2024 | 107.93B |
March 07, 2024 | 107.98B |
March 06, 2024 | 107.39B |
March 05, 2024 | 106.80B |
March 04, 2024 | 107.41B |
March 01, 2024 | 106.97B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
45.92B
Minimum
Mar 23 2020
117.47B
Maximum
May 09 2024
72.05B
Average
68.57B
Median
Dec 27 2021
Enterprise Value Benchmarks
ResMed Inc | 32.62B |
Stryker Corp | 136.50B |
Align Technology Inc | 20.22B |
Abbott Laboratories | 190.26B |
Axonics Inc | 3.107B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 492.00M |
Revenue (Quarterly) | 3.856B |
Total Expenses (Quarterly) | 3.163B |
EPS Diluted (Quarterly) | 0.33 |
Gross Profit Margin (Quarterly) | 68.65% |
Profit Margin (Quarterly) | 12.76% |
Earnings Yield | 1.62% |
Operating Earnings Yield | 2.33% |
Normalized Earnings Yield | 1.742 |